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I. INTRODUCTION
In preclinical molecular imaging, large in-
terest exists for absolute quantification of
µSPECT (Single Photon Emission Computed
Tomography) images. To date, µSPECT im-
ages are only qualitative or semi-quantitative.
Although these images permit the comparison
of different regions in the brain or the uptake
estimation in a tumor, great progress in preclin-
ical research is expected from absolute quan-
tification, since this would allow an accurate
evaluation of disease progression and therapy
or drug effectiveness in the same small ani-
mal. Indium-111 (111In) can be used for in vivo
evaluation of tumor selectivity, and hence the
potential therapeutic performance of a tracer.
The monoclonal antibody 14C5 for example,
labeled to 111In-DOTA or 111In-DTPA, has
shown to be a promising new antibody for tar-
geting pancreatic cancer cells. As mentioned
by Hwang et al [1], photon scatter is one of the
limiting factors for quantitative imaging. The
aim of this study was to investigate a scatter
correction method using five energy windows
(FEW) for 111In µSPECT imaging.
II. MATERIALS AND METHODS
A. FEW scatter correction method
Our scatter correction method requires 5 en-
ergy windows (EW): a 20% main EW around
each photopeak, an 8% scatter EW at both sides
of the 171keV photopeak and an 8% scatter EW
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at the left-hand side of the 245keV photopeak.
In Fig.1 the EWs and the estimated amount of
scatter present in the photopeaks are shown.
Figure 1. FEW scatter correction method.
B. Simulation study
As the contribution of scatter in small ani-
mals is known to stay limited for 111In, one
could wonder whether it is useful to apply scat-
ter correction in preclinical studies. However,
next to phantom scatter, collimator scatter and
backscatter also have to be considered. To
quantify the total scatter contribution present
in both photopeaks, a Monte Carlo simulation
of a digital mouse phantom (MOBY) [2] was
performed. The simulation was carried out us-
ing GATE [3] (Geant4 Application for Tomo-
graphic Emission). A realistic mouse study,
where MOBY was stepwise moved through the
U-SPECT II (Milabs) [4] system, was imitated.
C. Experimental measurements
To evaluate the FEW scatter correction tech-
nique, a preclinical study was performed.
Three tumor-bearing mice were injected with
111In-DTPA-14C5 or 111In-DOTA-14C5. They
were scanned with the U-SPECT II system be-
tween 48 and 72 hours after antibody injection,
since tumor uptake has shown to be the highest
in this time range. After acquisitions, image
reconstruction was performed with the scan-
ner software (OSEM algorithm with 16 subsets
and 3 iterations) to create an uncorrected and a
FEW corrected image of each mouse. A tumor-
to-background ratio (mean pixel value in the tu-
mor divided by the mean pixel value in a back-
ground ratio) was then computed for all recon-
structed images.
III. RESULTS
A. Simulation study
The 111In energy spectrum obtained for the
MOBY simulation is shown in Fig.2: the total
amount of detected photons and the complete
scatter contribution are shown. We could de-
duce that the number of scattered photons equal
32.6% and 12.1% of the total amount of de-
tected photons in respectively the first and sec-
ond photopeak. Taking a closer look at the dif-
ferent scatter types demonstrated that the con-
tribution of phantom scatter stays limited to
only 8% and 3% of the total number of counts
in the photopeaks. So, it are collimator scat-
ter and backscatter which account for the most
important part of scatter contamination.
B. Preclinical mouse study
The tumor-to-background ratios obtained for
the three mice are 4.0 (DTPA), 4.9 (DTPA) and
5.2 (DOTA) without any correction, while the
corresponding values after FEW scatter correc-
tion equal 4.7, 6.0 and 6.9. This means that our
scatter correction technique gives rise to an av-
erage improvement of 24%.
Figure 2. The 111In energy spectrum.
IV. CONCLUSION
This study presented a FEW scatter correc-
tion technique for 111In images. As we showed
that scatter contamination, especially collima-
tor scatter and backscatter, accounts for a sig-
nificant contribution in both photopeaks, our
scatter correction method may offer an impor-
tant improvement in the absolute quantification
of 111In µSPECT images for realistic preclini-
cal studies.
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